Name:
Lead(II) Iodide 99%
Synonym:
CAS:
10101-63-0
Section 1 - Chemical Product
MSDS Name:Lead(II) Iodide 99%
Synonym:
Synonym:
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 10101-63-0 | Lead (II) Iodide | 99 | 233-256-9 |
| Hazard Symbols: T N Risk Phrases: 20/22 33 61 62 50/53 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative effects. May cause harm to the unborn child. Possible risk of impaired fertility. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation. Causes eye irritation and possible injury.
Skin:
May cause skin irritation. Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with nausea, vomiting and diarrhea. May cause liver and kidney damage.
May cause cardiac disturbances. Exposure may cause anemia and other blood abnormalities. Ingestion of lead compounds can produce symptoms of lead poisoning. Symptoms of lead poisoning or plumbism include weakness, weight loss, lassitude, insomnia, and hypotension.
It also includes constipation, anorexia, abdominal discomfort and colic. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. Inhalation of fumes may cause metal fume fever, which is characterized by flu-like symptoms with metallic taste, fever, chills, cough, weakness, chest pain, muscle pain and increased white blood cell count. May cause effects similar to those described for ingestion.
May cause anemia. May cause cardiac abnormalities.
Chronic:
May cause liver and kidney damage. May cause cancer in humans.
Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.
Harmful by inhalation and if swallowed. Danger of cumulative effects. May cause harm to the unborn child. Possible risk of impaired fertility. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation. Causes eye irritation and possible injury.
Skin:
May cause skin irritation. Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with nausea, vomiting and diarrhea. May cause liver and kidney damage.
May cause cardiac disturbances. Exposure may cause anemia and other blood abnormalities. Ingestion of lead compounds can produce symptoms of lead poisoning. Symptoms of lead poisoning or plumbism include weakness, weight loss, lassitude, insomnia, and hypotension.
It also includes constipation, anorexia, abdominal discomfort and colic. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. Inhalation of fumes may cause metal fume fever, which is characterized by flu-like symptoms with metallic taste, fever, chills, cough, weakness, chest pain, muscle pain and increased white blood cell count. May cause effects similar to those described for ingestion.
May cause anemia. May cause cardiac abnormalities.
Chronic:
May cause liver and kidney damage. May cause cancer in humans.
Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
Antidote: The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel. The use of Calcium disodium EDTA as a chelating agent should be determined by qualified medical personnel.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
Antidote: The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel. The use of Calcium disodium EDTA as a chelating agent should be determined by qualified medical personnel.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode when heated. Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use water spray, fog or regular foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode when heated. Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use water spray, fog or regular foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool place in the original container and protect from sunlight. Store in a tightly closed container. Keep from contact with oxidizing materials.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool place in the original container and protect from sunlight. Store in a tightly closed container. Keep from contact with oxidizing materials.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 10101-63-0: United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3 (as Pb) United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m TWA (as Pb) United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level ( Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3 (dust and fume) France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le compounds, as Pb) Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA ( Pb) Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA (dust and smoke, as Pb) Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED ( Pb) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 10101-63-0: United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3 (as Pb) United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m TWA (as Pb) United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level ( Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3 (dust and fume) France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le compounds, as Pb) Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA ( Pb) Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA (dust and smoke, as Pb) Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED ( Pb) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Powder
Color: orange
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 402 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 6.1600g/cm3
Molecular Formula: I2Pb
Molecular Weight: 461.00
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen iodide, lead/lead oxides.
Hazardous Polymerization: Has not been reported
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen iodide, lead/lead oxides.
Hazardous Polymerization: Has not been reported
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 10101-63-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead (II) Iodide - California: carcinogen, initial date 10/1/92 (listed as Lead compounds NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
CAS# 10101-63-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead (II) Iodide - California: carcinogen, initial date 10/1/92 (listed as Lead compounds NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III
USA RQ: CAS# 10101-63-0: 10 lb final RQ; 4.54 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 10101-63-0: No information available.
Canada
CAS# 10101-63-0 is listed on Canadas NDSL List.
CAS# 10101-63-0 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10101-63-0 is listed on the TSCA inventory.
